ArticleJournal of Crohn's & colitis2025

Anti-tumor necrosis factor treatment from diagnosis is more effective and less costly than conventional "step-up" care for patients with active Crohn's disease: a cost-effectiveness analysis from the PROFILE trial.

Nurulamin M Noor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.